<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr>
<td align="center" stylecode="Lrule Rrule Toprule Botrule" valign="middle">
<paragraph>
<content stylecode="bold">
<content stylecode="emphasis">Drugs That May Increase Serum TBG Concentration</content>
</content>
</paragraph>
</td>
<td align="left" stylecode="Lrule Rrule Toprule Botrule" valign="bottom">
<paragraph>
<content stylecode="bold">
<content stylecode="emphasis">Drugs That May Decrease Serum TBG Concentration                                                                           <br/>
</content>
</content>
</paragraph>
</td>
</tr>
<tr>
<td align="left" stylecode="Lrule Rrule Toprule Botrule" valign="top">
<paragraph>Clofibrate</paragraph>
<paragraph>Estrogen-containing oral contraceptives</paragraph>
<paragraph>Estrogens (oral)</paragraph>
<paragraph>Heroin / Methadone</paragraph>
<paragraph>5-Fluorouracil</paragraph>
<paragraph>Mitotane</paragraph>
<paragraph>Tamoxifen</paragraph>
</td>
<td align="left" stylecode="Lrule Rrule Toprule Botrule" valign="top">
<paragraph>Androgens / Anabolic Steroids</paragraph>
<paragraph>Asparaginase</paragraph>
<paragraph>Glucocorticoids</paragraph>
<paragraph>Slow-Release Nicotinic Acid</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="2" stylecode="Lrule Rrule Toprule Botrule" valign="middle">
<paragraph>
<content stylecode="bold">
<content stylecode="emphasis">                                                                         Drugs That May Cause Protein-Binding Site Displacement</content>
</content>
</paragraph>
<paragraph>Potential impact<content stylecode="bold">
<content stylecode="emphasis">:</content>
</content> Administration of these agents with levothyroxine results in an initial transient increase in FT<sub>4</sub>.  Continued administration results in a decrease in serum T<sub>4</sub> and normal FT<sub>4</sub> and TSH concentrations and, therefore, patients are clinically euthyroid.</paragraph>
</td>
</tr>
<tr>
<td align="left" stylecode="Lrule Rrule Toprule Botrule" valign="top">
<paragraph>Salicylates (&gt; 2 g/day)</paragraph>
</td>
<td align="left" stylecode="Lrule Rrule Toprule Botrule" valign="top">
<paragraph>Salicylates inhibit binding of T<sub>4</sub> and T<sub>3</sub> to TBG and transthyretin.  An initial increase in serum FT<sub>4</sub> is followed by return of FT<sub>4</sub> to normal levels with sustained therapeutic serum salicylate concentrations, although total-T<sub>4</sub> levels may decrease by as much as 30%.</paragraph>
</td>
</tr>
<tr>
<td align="left" stylecode="Lrule Rrule Toprule Botrule" valign="top">
<paragraph>Other drugs:</paragraph>
<paragraph>Furosemide (&gt; 80 mg IV)</paragraph>
<paragraph>Heparin </paragraph>
<paragraph>Hydantoins </paragraph>
<paragraph>Non-Steroidal Anti-inflammatory Drugs</paragraph>
<paragraph>- Fenamates</paragraph>
<paragraph>- Phenylbutazone</paragraph>
</td>
<td align="left" stylecode="Lrule Rrule Toprule Botrule" valign="top">
<paragraph> </paragraph>
</td>
</tr>
</tbody>
</table>